Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16675963rdf:typepubmed:Citationlld:pubmed
pubmed-article:16675963lifeskim:mentionsumls-concept:C0016030lld:lifeskim
pubmed-article:16675963lifeskim:mentionsumls-concept:C0036420lld:lifeskim
pubmed-article:16675963lifeskim:mentionsumls-concept:C0221928lld:lifeskim
pubmed-article:16675963lifeskim:mentionsumls-concept:C0083026lld:lifeskim
pubmed-article:16675963lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:16675963lifeskim:mentionsumls-concept:C0040690lld:lifeskim
pubmed-article:16675963lifeskim:mentionsumls-concept:C0596138lld:lifeskim
pubmed-article:16675963lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:16675963lifeskim:mentionsumls-concept:C1441547lld:lifeskim
pubmed-article:16675963lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:16675963pubmed:issue8lld:pubmed
pubmed-article:16675963pubmed:dateCreated2006-7-17lld:pubmed
pubmed-article:16675963pubmed:abstractTextLocalized scleroderma (LSc) is a connective tissue disorder limited to skin and subcutaneous tissue, which may share pathogenic processes with systemic sclerosis (SSc). We previously demonstrated that upregulated expression of integrin alphavbeta5 might contribute to autocrine TGF-beta signaling in SSc fibroblasts. Based on these data, we presently focused on alphavbeta5 and assessed its involvement in pathogenesis of LSc. We initially demonstrated that LSc fibroblasts might be activated by the stimulation of autocrine TGF-beta. Consistent with SSc fibroblasts, expression levels of alphavbeta5 were elevated in LSc fibroblasts in vitro and in vivo. Anti-alphavbeta5 antibody partially reversed expression levels of type I procollagen and MMP-1 and constitutive DNA-Smad3 binding in LSc fibroblasts. In LSc fibroblasts pretreated with antisense TGF-beta1, exogenous latent TGF-beta1 stimulation increased expression of type I procollagen in an alphavbeta5-dependent manner. The luciferase activities of TMLC cells, Mv1Lu cells stably expressing a portion of the plasminogen activator inhibitor 1 promoter, co-cultured with LSc fibroblasts were significantly elevated compared with those co-cultured with normal fibroblasts and were significantly reduced in the presence of anti-alphavbeta5 antibody. Anti-alphavbeta5 antibody reversed the myofibroblastic features of LSc fibroblasts. These results indicate that upregulated expression of alphavbeta5 contributes to autocrine TGF-beta signaling in LSc fibroblasts.lld:pubmed
pubmed-article:16675963pubmed:languageenglld:pubmed
pubmed-article:16675963pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16675963pubmed:citationSubsetIMlld:pubmed
pubmed-article:16675963pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16675963pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16675963pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16675963pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16675963pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16675963pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16675963pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16675963pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16675963pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16675963pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16675963pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16675963pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16675963pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16675963pubmed:statusMEDLINElld:pubmed
pubmed-article:16675963pubmed:monthAuglld:pubmed
pubmed-article:16675963pubmed:issn0022-202Xlld:pubmed
pubmed-article:16675963pubmed:authorpubmed-author:IhnHironobuHlld:pubmed
pubmed-article:16675963pubmed:authorpubmed-author:AsanoYoshihid...lld:pubmed
pubmed-article:16675963pubmed:authorpubmed-author:TamakiKunihik...lld:pubmed
pubmed-article:16675963pubmed:authorpubmed-author:JinninMasatos...lld:pubmed
pubmed-article:16675963pubmed:authorpubmed-author:MimuraYoshihi...lld:pubmed
pubmed-article:16675963pubmed:issnTypePrintlld:pubmed
pubmed-article:16675963pubmed:volume126lld:pubmed
pubmed-article:16675963pubmed:ownerNLMlld:pubmed
pubmed-article:16675963pubmed:authorsCompleteYlld:pubmed
pubmed-article:16675963pubmed:pagination1761-9lld:pubmed
pubmed-article:16675963pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16675963pubmed:meshHeadingpubmed-meshheading:16675963...lld:pubmed
pubmed-article:16675963pubmed:meshHeadingpubmed-meshheading:16675963...lld:pubmed
pubmed-article:16675963pubmed:meshHeadingpubmed-meshheading:16675963...lld:pubmed
pubmed-article:16675963pubmed:meshHeadingpubmed-meshheading:16675963...lld:pubmed
pubmed-article:16675963pubmed:meshHeadingpubmed-meshheading:16675963...lld:pubmed
pubmed-article:16675963pubmed:meshHeadingpubmed-meshheading:16675963...lld:pubmed
pubmed-article:16675963pubmed:meshHeadingpubmed-meshheading:16675963...lld:pubmed
pubmed-article:16675963pubmed:meshHeadingpubmed-meshheading:16675963...lld:pubmed
pubmed-article:16675963pubmed:meshHeadingpubmed-meshheading:16675963...lld:pubmed
pubmed-article:16675963pubmed:meshHeadingpubmed-meshheading:16675963...lld:pubmed
pubmed-article:16675963pubmed:meshHeadingpubmed-meshheading:16675963...lld:pubmed
pubmed-article:16675963pubmed:meshHeadingpubmed-meshheading:16675963...lld:pubmed
pubmed-article:16675963pubmed:meshHeadingpubmed-meshheading:16675963...lld:pubmed
pubmed-article:16675963pubmed:meshHeadingpubmed-meshheading:16675963...lld:pubmed
pubmed-article:16675963pubmed:meshHeadingpubmed-meshheading:16675963...lld:pubmed
pubmed-article:16675963pubmed:meshHeadingpubmed-meshheading:16675963...lld:pubmed
pubmed-article:16675963pubmed:meshHeadingpubmed-meshheading:16675963...lld:pubmed
pubmed-article:16675963pubmed:meshHeadingpubmed-meshheading:16675963...lld:pubmed
pubmed-article:16675963pubmed:meshHeadingpubmed-meshheading:16675963...lld:pubmed
pubmed-article:16675963pubmed:meshHeadingpubmed-meshheading:16675963...lld:pubmed
pubmed-article:16675963pubmed:year2006lld:pubmed
pubmed-article:16675963pubmed:articleTitleInvolvement of alphavbeta5 integrin in the establishment of autocrine TGF-beta signaling in dermal fibroblasts derived from localized scleroderma.lld:pubmed
pubmed-article:16675963pubmed:affiliationDepartment of Dermatology, Faculty of Medicine, University of Tokyo, Kumamoto University, Kumamoto, Japan.lld:pubmed
pubmed-article:16675963pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:3685entrezgene:pubmedpubmed-article:16675963lld:entrezgene
entrez-gene:3693entrezgene:pubmedpubmed-article:16675963lld:entrezgene
entrez-gene:7040entrezgene:pubmedpubmed-article:16675963lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16675963lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16675963lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16675963lld:entrezgene
lhgdn:association:282lhgdn:found_inpubmed-article:16675963lld:lhgdn
lhgdn:association:56059lhgdn:found_inpubmed-article:16675963lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16675963lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16675963lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16675963lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16675963lld:pubmed